$MGX

Abu Dhabi’s MGX weighs multi-billion deal for Singapore-based data centre operator DayOne: sources

MGX, an Abu Dhabi-backed AI investor, is exploring a multi-billion acquisition of Singapore-based data centre operator DayOne, three sources said. MGX has worked with an investment bank on the potential deal. DayOne plans a US IPO targeting a $20bn valuation, which MGX may not match; talks may not lead to a deal. DayOne is affiliated with GDS Holdings.

Original reporting
Published Jun 20, 2026, 6:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 20, 2026, 8:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Abu Dhabi’s MGX weighs multi-billion deal for Singapore-based data centre operator DayOne: sources — source image
Decision brief

The 30-second read

$MGXNeutralLow
01

Why it matters

If talks progress, traders may reprice the probability of a takeover versus an IPO; however, the report is conditional and lacks deal terms.

02

Market read

M&A speculation around a major AI data-centre operator intersects with an IPO plan, but confirmation and pricing are missing.

03

What to watch

The article doesn’t specify financing, governance/lockups, or whether DayOne’s dual-IPO plans constrain an acquisition timeline.

Relevance 4/10Novelty 4/10Timing: today’s pre-deal speculation ahead of any IPO/M&A confirmation

Background

DayOne is described as affiliated with GDS Holdings and operating data centres across Southeast Asia plus Hong Kong, Japan, and Finland; it has planned a US IPO targeting a $20B valuation.

Company-level read

Ticker impact

$MGXNeutralLow confidence
Context

Article says Abu Dhabi AI investor MGX is exploring a multi-billion acquisition of Singapore data-centre operator DayOne, with talks via a bank.

Expected impact

No direct tradable price impact is implied because MGX is not identified as a US-listed ticker in the article.

Evidence & confidence

The piece is a sources-based M&A exploration story with no disclosed bid price, structure, or confirmation; MGX’s tradability is unclear from the text.

Market effects

Highlights continued consolidation/strategic interest in AI data-centre infrastructure and cross-border expansion.

Could increase deal/IPO attention on Singapore and broader Southeast Asia data-centre operators.

Signals UAE AI capital deployment into global infrastructure, potentially affecting competitive dynamics for AI capacity.

Counterpoint

MGX may ultimately prefer DayOne’s IPO route or walk away if valuation expectations diverge, limiting any near-term takeover premium.

Key entities

  • MGX

    Abu Dhabi-backed AI investor exploring a potential acquisition of DayOne.

  • DayOne

    Singapore-based data-centre operator planning a US IPO targeting a $20B valuation.

Related articles

$MGXMed

Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Metagenomi Therapeutics, Inc. (MGX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results Remains on track to submit investigational new drug (IND) application in 4Q 2026 for the global clinical program of MGX-001 for the treatment of hemophilia A $120.7 million in

$VHighAI 9/10

Visa (V) Advances Talks to Acquire Fireblocks, Expanding Crypto

Visa (V) is in advanced talks to acquire Fireblocks for $2.5B, expanding its crypto infrastructure. Visa's stock is fairly valued at $407.92, matching its GF Value of $408.12. The company has a GF Score of 98/100, with strong profitability and growth. Insiders sold $86.3M in shares over the past year, while gurus show mixed activity.

$UBSMed

UBS Acquires 4.8% Equity Stake In 360 ONE WAM

UBS AG acquired a 4.8% equity stake in 360 ONE WAM Ltd. after exercising 20,502,939 warrants. This investment strengthens UBS's strategic relationship with the Indian wealth and asset management firm, aligning with its global growth strategy. As of Q2 2026, UBS managed $7.3 trillion in assets.

HighAI 9/10

Cencora Agrees to Take Controlling Stake in American Oncology Network in $2.4 Billion Deal Spanning 21 States

Cencora agreed to acquire American Oncology Network (AON) for $2.4 billion, expanding its oncology services. The deal, pending approval, includes $2.3 billion at closing plus up to $100 million in contingent value rights. Cencora already owns 4% of AON and aims to increase its stake to 75%. The acquisition is part of a broader trend of drug wholesalers buying cancer practice management companies.